Article Versions Notes

Zöllner SK, Kauertz KL, Kaiser I, Kerkhoff M, Schaefer C, Tassius M, Jabar S, Jürgens H, Ladenstein R, Kühne T, et al. Ewing Sarcoma as Secondary Malignant Neoplasm—Epidemiological and Clinical Analysis of an International Trial Registry. Cancers. 2022; 14(23):5935. https://doi.org/10.3390/cancers14235935

Zöllner, Stefan K., Katja L. Kauertz, Isabelle Kaiser, Maximilian Kerkhoff, Christiane Schaefer, Madita Tassius, Susanne Jabar, Heribert Jürgens, Ruth Ladenstein, Thomas Kühne, and et al. 2022. "Ewing Sarcoma as Secondary Malignant Neoplasm—Epidemiological and Clinical Analysis of an International Trial Registry" Cancers 14, no. 23: 5935. https://doi.org/10.3390/cancers14235935

Zöllner, S. K., Kauertz, K. L., Kaiser, I., Kerkhoff, M., Schaefer, C., Tassius, M., Jabar, S., Jürgens, H., Ladenstein, R., Kühne, T., Haveman, L. M., Paulussen, M., Ranft, A., & Dirksen, U. (2022). Ewing Sarcoma as Secondary Malignant Neoplasm—Epidemiological and Clinical Analysis of an International Trial Registry. Cancers, 14(23), 5935. https://doi.org/10.3390/cancers14235935